+关注
丁征武_8782
暂无个人介绍
IP属地：浙江
13
关注
1
粉丝
1
主题
0
勋章
主贴
热门
丁征武_8782
2020-06-05
开始拉高了
@edward28:
$Sorrento Therapeutics Inc.(SRNE)$
以为是拉高出货就傻了，做空得小心。
丁征武_8782
08-22
这篇文章不错，转发给大家看看
@同壁财经:合成生物学技术应用受关注，港股创新药ETF（159567）上行，荣昌生物、石药集团、康哲药业、康希诺生物等领涨
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3542598338700662","uuid":"3542598338700662","gmtCreate":1579514042823,"gmtModify":1579682845300,"name":"丁征武_8782","pinyin":"dzw8782dingzhengwu8782","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/ecad9f9ccaf13ae5f92695731cf4a1fd","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":13,"tweetSize":2,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.02.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.26%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.96%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":"浙江","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":1,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":341245043708128,"gmtCreate":1724332327944,"gmtModify":1724332975099,"author":{"id":"3542598338700662","authorId":"3542598338700662","name":"丁征武_8782","avatar":"https://static.tigerbbs.com/ecad9f9ccaf13ae5f92695731cf4a1fd","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3542598338700662","authorIdStr":"3542598338700662"},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/341245043708128","repostId":"310714067230736","repostType":1,"repost":{"id":310714067230736,"gmtCreate":1716885788130,"gmtModify":1716885791933,"author":{"id":"4135467327484010","authorId":"4135467327484010","name":"同壁财经","avatar":"https://static.tigerbbs.com/4f343874740bbf9170eaa2762e82b228","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4135467327484010","authorIdStr":"4135467327484010"},"themes":[],"title":"合成生物学技术应用受关注，港股创新药ETF（159567）上行，荣昌生物、石药集团、康哲药业、康希诺生物等领涨","htmlText":"5月28日，港股创新药概念逆势上升。盘面上，荣昌生物、石药集团、康哲药业、康希诺生物等领涨。港股创新药ETF（159567）表现活跃。 光大证券表示，近期合成生物学概念火爆，合成生物学采用了工程化的设计理念，改造或创造超越自然功能的人造生命体系或功能系统，广义而言可被界定为以生物基材料替代化石基材料、以生物技术路线替代传统化工技术路线的科技产业。其在生物医药领域的应用，主要在创新药及创新疗法、原料药和医药中间体两大方向。同时，若港股通红利税减免，则将对港股医药板块产生利好，部分高股息的医药股将受益于红利税减免政策。港股和创新药双重利好背景下，港股创新药ETF（159567）投资价值较高。","listText":"5月28日，港股创新药概念逆势上升。盘面上，荣昌生物、石药集团、康哲药业、康希诺生物等领涨。港股创新药ETF（159567）表现活跃。 光大证券表示，近期合成生物学概念火爆，合成生物学采用了工程化的设计理念，改造或创造超越自然功能的人造生命体系或功能系统，广义而言可被界定为以生物基材料替代化石基材料、以生物技术路线替代传统化工技术路线的科技产业。其在生物医药领域的应用，主要在创新药及创新疗法、原料药和医药中间体两大方向。同时，若港股通红利税减免，则将对港股医药板块产生利好，部分高股息的医药股将受益于红利税减免政策。港股和创新药双重利好背景下，港股创新药ETF（159567）投资价值较高。","text":"5月28日，港股创新药概念逆势上升。盘面上，荣昌生物、石药集团、康哲药业、康希诺生物等领涨。港股创新药ETF（159567）表现活跃。 光大证券表示，近期合成生物学概念火爆，合成生物学采用了工程化的设计理念，改造或创造超越自然功能的人造生命体系或功能系统，广义而言可被界定为以生物基材料替代化石基材料、以生物技术路线替代传统化工技术路线的科技产业。其在生物医药领域的应用，主要在创新药及创新疗法、原料药和医药中间体两大方向。同时，若港股通红利税减免，则将对港股医药板块产生利好，部分高股息的医药股将受益于红利税减免政策。港股和创新药双重利好背景下，港股创新药ETF（159567）投资价值较高。","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/310714067230736","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":164,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":958757164,"gmtCreate":1591368280858,"gmtModify":1704195625036,"author":{"id":"3542598338700662","authorId":"3542598338700662","name":"丁征武_8782","avatar":"https://static.tigerbbs.com/ecad9f9ccaf13ae5f92695731cf4a1fd","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3542598338700662","authorIdStr":"3542598338700662"},"themes":[],"htmlText":"开始拉高了","listText":"开始拉高了","text":"开始拉高了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/958757164","repostId":"958733972","repostType":1,"repost":{"id":958733972,"gmtCreate":1591364861296,"gmtModify":1704195545103,"author":{"id":"3540880674211350","authorId":"3540880674211350","name":"edward28","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3540880674211350","authorIdStr":"3540880674211350"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SRNE\">$Sorrento Therapeutics Inc.(SRNE)$</a>以为是拉高出货就傻了，做空得小心。","listText":"<a href=\"https://laohu8.com/S/SRNE\">$Sorrento Therapeutics Inc.(SRNE)$</a>以为是拉高出货就傻了，做空得小心。","text":"$Sorrento Therapeutics Inc.(SRNE)$以为是拉高出货就傻了，做空得小心。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/958733972","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1209,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"idStr":"3527667803686145","authorIdStr":"3527667803686145"},"content":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引","text":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引","html":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引"}],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":958757164,"gmtCreate":1591368280858,"gmtModify":1704195625036,"author":{"id":"3542598338700662","authorId":"3542598338700662","name":"丁征武_8782","avatar":"https://static.tigerbbs.com/ecad9f9ccaf13ae5f92695731cf4a1fd","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3542598338700662","authorIdStr":"3542598338700662"},"themes":[],"htmlText":"开始拉高了","listText":"开始拉高了","text":"开始拉高了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/958757164","repostId":"958733972","repostType":1,"repost":{"id":958733972,"gmtCreate":1591364861296,"gmtModify":1704195545103,"author":{"id":"3540880674211350","authorId":"3540880674211350","name":"edward28","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3540880674211350","authorIdStr":"3540880674211350"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SRNE\">$Sorrento Therapeutics Inc.(SRNE)$</a>以为是拉高出货就傻了，做空得小心。","listText":"<a href=\"https://laohu8.com/S/SRNE\">$Sorrento Therapeutics Inc.(SRNE)$</a>以为是拉高出货就傻了，做空得小心。","text":"$Sorrento Therapeutics Inc.(SRNE)$以为是拉高出货就傻了，做空得小心。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/958733972","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1209,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"idStr":"3527667803686145","authorIdStr":"3527667803686145"},"content":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引","text":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引","html":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":341245043708128,"gmtCreate":1724332327944,"gmtModify":1724332975099,"author":{"id":"3542598338700662","authorId":"3542598338700662","name":"丁征武_8782","avatar":"https://static.tigerbbs.com/ecad9f9ccaf13ae5f92695731cf4a1fd","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3542598338700662","authorIdStr":"3542598338700662"},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/341245043708128","repostId":"310714067230736","repostType":1,"repost":{"id":310714067230736,"gmtCreate":1716885788130,"gmtModify":1716885791933,"author":{"id":"4135467327484010","authorId":"4135467327484010","name":"同壁财经","avatar":"https://static.tigerbbs.com/4f343874740bbf9170eaa2762e82b228","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4135467327484010","authorIdStr":"4135467327484010"},"themes":[],"title":"合成生物学技术应用受关注，港股创新药ETF（159567）上行，荣昌生物、石药集团、康哲药业、康希诺生物等领涨","htmlText":"5月28日，港股创新药概念逆势上升。盘面上，荣昌生物、石药集团、康哲药业、康希诺生物等领涨。港股创新药ETF（159567）表现活跃。 光大证券表示，近期合成生物学概念火爆，合成生物学采用了工程化的设计理念，改造或创造超越自然功能的人造生命体系或功能系统，广义而言可被界定为以生物基材料替代化石基材料、以生物技术路线替代传统化工技术路线的科技产业。其在生物医药领域的应用，主要在创新药及创新疗法、原料药和医药中间体两大方向。同时，若港股通红利税减免，则将对港股医药板块产生利好，部分高股息的医药股将受益于红利税减免政策。港股和创新药双重利好背景下，港股创新药ETF（159567）投资价值较高。","listText":"5月28日，港股创新药概念逆势上升。盘面上，荣昌生物、石药集团、康哲药业、康希诺生物等领涨。港股创新药ETF（159567）表现活跃。 光大证券表示，近期合成生物学概念火爆，合成生物学采用了工程化的设计理念，改造或创造超越自然功能的人造生命体系或功能系统，广义而言可被界定为以生物基材料替代化石基材料、以生物技术路线替代传统化工技术路线的科技产业。其在生物医药领域的应用，主要在创新药及创新疗法、原料药和医药中间体两大方向。同时，若港股通红利税减免，则将对港股医药板块产生利好，部分高股息的医药股将受益于红利税减免政策。港股和创新药双重利好背景下，港股创新药ETF（159567）投资价值较高。","text":"5月28日，港股创新药概念逆势上升。盘面上，荣昌生物、石药集团、康哲药业、康希诺生物等领涨。港股创新药ETF（159567）表现活跃。 光大证券表示，近期合成生物学概念火爆，合成生物学采用了工程化的设计理念，改造或创造超越自然功能的人造生命体系或功能系统，广义而言可被界定为以生物基材料替代化石基材料、以生物技术路线替代传统化工技术路线的科技产业。其在生物医药领域的应用，主要在创新药及创新疗法、原料药和医药中间体两大方向。同时，若港股通红利税减免，则将对港股医药板块产生利好，部分高股息的医药股将受益于红利税减免政策。港股和创新药双重利好背景下，港股创新药ETF（159567）投资价值较高。","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/310714067230736","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":164,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}
